Cargando…

Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus

BACKGROUND: There are no risk scores available for predicting heart failure in Type 2 diabetes mellitus (T2DM). Based on the Hong Kong Diabetes Registry, this study aimed to develop and validate a risk score for predicting heart failure that needs hospitalisation in T2DM. METHODS: 7067 Hong Kong Chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xilin, Ma, Ronald C, So, Wing-Yee, Kong, Alice P, Ko, Gary T, Ho, Chun-Shun, Lam, Christopher W, Cockram, Clive S, Tong, Peter C, Chan, Juliana C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377240/
https://www.ncbi.nlm.nih.gov/pubmed/18430204
http://dx.doi.org/10.1186/1475-2840-7-9
_version_ 1782154797880705024
author Yang, Xilin
Ma, Ronald C
So, Wing-Yee
Kong, Alice P
Ko, Gary T
Ho, Chun-Shun
Lam, Christopher W
Cockram, Clive S
Tong, Peter C
Chan, Juliana C
author_facet Yang, Xilin
Ma, Ronald C
So, Wing-Yee
Kong, Alice P
Ko, Gary T
Ho, Chun-Shun
Lam, Christopher W
Cockram, Clive S
Tong, Peter C
Chan, Juliana C
author_sort Yang, Xilin
collection PubMed
description BACKGROUND: There are no risk scores available for predicting heart failure in Type 2 diabetes mellitus (T2DM). Based on the Hong Kong Diabetes Registry, this study aimed to develop and validate a risk score for predicting heart failure that needs hospitalisation in T2DM. METHODS: 7067 Hong Kong Chinese diabetes patients without history of heart failure, and without history and clinical evidence of coronary heart disease at baseline were analyzed. The subjects have been followed up for a median period of 5.5 years. Data were randomly and evenly assigned to a training dataset and a test dataset. Sex-stratified Cox proportional hazard regression was used to obtain predictors of HF-related hospitalization in the training dataset. Calibration was assessed using Hosmer-Lemeshow test and discrimination was examined using the area under receiver's operating characteristic curve (aROC) in the test dataset. RESULTS: During the follow-up, 274 patients developed heart failure event/s that needed hospitalisation. Age, body mass index (BMI), spot urinary albumin to creatinine ratio (ACR), HbA(1c), blood haemoglobin (Hb) at baseline and coronary heart disease during follow-up were predictors of HF-related hospitalization in the training dataset. HF-related hospitalization risk score = 0.0709 × age (year) + 0.0627 × BMI (kg/m(2)) + 0.1363 × HbA(1c)(%) + 0.9915 × Log(10)(1+ACR) (mg/mmol) - 0.3606 × Blood Hb(g/dL) + 0.8161 × CHD during follow-up (1 if yes). The 5-year probability of heart failure = 1-S(0)(5)(EXP{0.9744 × (Risk Score - 2.3961)}). Where S(0)(5) = 0.9888 if male and 0.9809 if female. The predicted and observed 5-year probabilities of HF-related hospitalization were similar (p > 0.20) and the adjusted aROC was 0.920 for 5 years of follow-up. CONCLUSION: The risk score had adequate performance. Further validations in other cohorts of patients with T2DM are needed before clinical use.
format Text
id pubmed-2377240
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23772402008-05-13 Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus Yang, Xilin Ma, Ronald C So, Wing-Yee Kong, Alice P Ko, Gary T Ho, Chun-Shun Lam, Christopher W Cockram, Clive S Tong, Peter C Chan, Juliana C Cardiovasc Diabetol Original Investigation BACKGROUND: There are no risk scores available for predicting heart failure in Type 2 diabetes mellitus (T2DM). Based on the Hong Kong Diabetes Registry, this study aimed to develop and validate a risk score for predicting heart failure that needs hospitalisation in T2DM. METHODS: 7067 Hong Kong Chinese diabetes patients without history of heart failure, and without history and clinical evidence of coronary heart disease at baseline were analyzed. The subjects have been followed up for a median period of 5.5 years. Data were randomly and evenly assigned to a training dataset and a test dataset. Sex-stratified Cox proportional hazard regression was used to obtain predictors of HF-related hospitalization in the training dataset. Calibration was assessed using Hosmer-Lemeshow test and discrimination was examined using the area under receiver's operating characteristic curve (aROC) in the test dataset. RESULTS: During the follow-up, 274 patients developed heart failure event/s that needed hospitalisation. Age, body mass index (BMI), spot urinary albumin to creatinine ratio (ACR), HbA(1c), blood haemoglobin (Hb) at baseline and coronary heart disease during follow-up were predictors of HF-related hospitalization in the training dataset. HF-related hospitalization risk score = 0.0709 × age (year) + 0.0627 × BMI (kg/m(2)) + 0.1363 × HbA(1c)(%) + 0.9915 × Log(10)(1+ACR) (mg/mmol) - 0.3606 × Blood Hb(g/dL) + 0.8161 × CHD during follow-up (1 if yes). The 5-year probability of heart failure = 1-S(0)(5)(EXP{0.9744 × (Risk Score - 2.3961)}). Where S(0)(5) = 0.9888 if male and 0.9809 if female. The predicted and observed 5-year probabilities of HF-related hospitalization were similar (p > 0.20) and the adjusted aROC was 0.920 for 5 years of follow-up. CONCLUSION: The risk score had adequate performance. Further validations in other cohorts of patients with T2DM are needed before clinical use. BioMed Central 2008-04-22 /pmc/articles/PMC2377240/ /pubmed/18430204 http://dx.doi.org/10.1186/1475-2840-7-9 Text en Copyright © 2008 Yang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigation
Yang, Xilin
Ma, Ronald C
So, Wing-Yee
Kong, Alice P
Ko, Gary T
Ho, Chun-Shun
Lam, Christopher W
Cockram, Clive S
Tong, Peter C
Chan, Juliana C
Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus
title Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus
title_full Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus
title_fullStr Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus
title_full_unstemmed Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus
title_short Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus
title_sort development and validation of a risk score for hospitalization for heart failure in patients with type 2 diabetes mellitus
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377240/
https://www.ncbi.nlm.nih.gov/pubmed/18430204
http://dx.doi.org/10.1186/1475-2840-7-9
work_keys_str_mv AT yangxilin developmentandvalidationofariskscoreforhospitalizationforheartfailureinpatientswithtype2diabetesmellitus
AT maronaldc developmentandvalidationofariskscoreforhospitalizationforheartfailureinpatientswithtype2diabetesmellitus
AT sowingyee developmentandvalidationofariskscoreforhospitalizationforheartfailureinpatientswithtype2diabetesmellitus
AT kongalicep developmentandvalidationofariskscoreforhospitalizationforheartfailureinpatientswithtype2diabetesmellitus
AT kogaryt developmentandvalidationofariskscoreforhospitalizationforheartfailureinpatientswithtype2diabetesmellitus
AT hochunshun developmentandvalidationofariskscoreforhospitalizationforheartfailureinpatientswithtype2diabetesmellitus
AT lamchristopherw developmentandvalidationofariskscoreforhospitalizationforheartfailureinpatientswithtype2diabetesmellitus
AT cockramclives developmentandvalidationofariskscoreforhospitalizationforheartfailureinpatientswithtype2diabetesmellitus
AT tongpeterc developmentandvalidationofariskscoreforhospitalizationforheartfailureinpatientswithtype2diabetesmellitus
AT chanjulianac developmentandvalidationofariskscoreforhospitalizationforheartfailureinpatientswithtype2diabetesmellitus